• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends

    Power Trip: A Discussion of Custom Medical Electronics

    The MDR Transition: An Opportunity for Design Change?

    Preserve and Protect: Sustainability Initiatives for Medtech Manufacturing
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    Heather Danks Named Chief Technology Officer at LEX Diagnostics

    Vitalchat Awarded Patent for Patient Monitoring, Bandwidth Conservation Tech

    South Korean Regulators Authorize Expanded NeuroStar TMS Indications

    Ian T. Meredith Joins Avertix Medical’s Board

    Hologic, Bayer Team Up for Contrast-Enhanced Mammography
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends

    Power Trip: A Discussion of Custom Medical Electronics

    The MDR Transition: An Opportunity for Design Change?

    Preserve and Protect: Sustainability Initiatives for Medtech Manufacturing
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Medtech’s Most Powerful M&A Drivers

    The Link Between Medtech and Connected Medical Devices

    Is the FTC Partly Responsible for Muted M&A Activity?

    Holistic Risk Management: Navigating the Future’s Uncertainties

    Defining End of Life for Medical Devices
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    NDH Medical Inc.

    Arthur G. Russell Co. Inc., The

    Johari Digital Healthcare Ltd.

    JBC Technologies

    Halkey-Roberts Corporation
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    A One-Stop-Shop, Turnkey Solution Is Paramount for Success

    How Additive and Subtractive Manufacturing Are Revolutionizing the Medical Device Industry

    Medical Device Commercialization: It’s What, Not When, to Transfer to Manufacturing

    How In Silico Simulations Can Slash Medical Device Development Risk

    The Top 7 AI Applications Transforming Medical Device Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    NDH Medical Inc.

    Arthur G. Russell Co. Inc., The

    Johari Digital Healthcare Ltd.

    JBC Technologies

    Halkey-Roberts Corporation
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Columns

    A Breakthrough for the Nightmarish Effects of PTSD

    ...

    A Breakthrough for the Nightmarish Effects of PTSD
    Sam Brusco, Associate Editor06.13.19
    Though I am not a particularly strong supporter of Apple—and you’re welcome to contact me to find out why—I have to admit the Apple Watch could be a useful tool for proactive health monitoring.

    The Apple Watch Series 4, released last year, came equipped with an electrocardiogram (ECG) sensor and app to capture the heart’s rhythm. The company did its homework and also obtained clearance from the U.S. Food and Drug Administration (FDA) for the ECG tool around the time of release. Health Canada also issued active licenses for the ECG and irregular heart rhythm notification features on May 16.

    Further affirming the feature’s utility, Stanford University School of Medicine shared the early results of a 400,000-participant study during the last week of April to determine if the mobile app could accurately identify atrial fibrillation (AFib). Stanford researchers reported the wearable technology can safely identify heart rate irregularities, which subsequent testing confirmed to be AFib.

    This clearance has opened the door for other health-conscious smartwatch applications running on the Apple Watch Platform. They don’t necessarily have to be directly cardiac related, either. For example, on May 21, NightWare Inc., a Minneapolis-based startup that develops digital therapeutics for mental health, received FDA Breakthrough Status for its NightWare product, which measures and treats nightmares for sufferers of post-traumatic stress disorder (PTSD).

    Among the many other disconcerting symptoms of PTSD, it is estimated that almost 5 million Americans suffer from Nightmare Disorder related to PTSD. Nightmares and Nightmare Disorder have long been associated with a slew of worrisome effects—increased suicidality, heightened heart disease risk and diabetes, and cognitive difficulties like memory loss, anxiety, and depression. A single nightmare event is enough to make anyone anxious or upset, but repeated nightmares and interrupted sleep can bring PTSD sufferers’ trauma to the forefront nearly every night.

    For those unfamiliar with what a Breakthrough Designation means, it occurs when the FDA recognizes a therapeutic solution for a life-threatening condition for which no currently approved treatment is able to offer similar benefits to the proposed therapy. This designation allows the FDA to grant priority review when preliminary clinical trials indicate a given therapy might offer substantial advantages over existing options for patients with serious or life-threatening diseases. A breakthrough therapy designation is requested by the company providing the solution. In some cases, the FDA may suggest the sponsor consider submitting a breakthrough request if, after reviewing the submitted data, the agency thinks the program might meet breakthrough criteria and the development program will benefit from the designation.

    “This is truly a watershed moment for our company,” NightWare CEO and founder Grady Hannah told the press. “In our initial studies, NightWare has demonstrated substantial and significant efficacy. The FDA’s Breakthrough Status designation will enable us to complete our Randomized Clinical Trials ahead of schedule and give us the opportunity to help improve the lives of veterans and others suffering from PTSD sooner than we anticipated. Our team is humbled and excited by this FDA designation.”

    The NightWare application operates by tracking, intervening, and processing nightmare events. As the wearer slumbers, the app continuously analyzes heart rate, accelerometer, and gyroscope data collected from the Apple Watch’s integrated sensors to learn sleep patterns in the first few days of wearing the watch each night. The “learning period” usually takes less than 10 days to apply machine learning algorithms for a profile of the individual’s sleep patterns. A “stress threshold” is computed during this time based on spikes in heart rate and movement, indicating a nightmare event has begun.

    Once the learning period is over, whenever the application detects a potential nightmare it intervenes by vibrating (also called vibrotactile feedback). The watch will vibrate enough to arouse the sleeper out of sleep without waking them. The intended result is the nightmare is interrupted by the sudden arousal without interrupting the sleeper’s circadian sleep pattern, allowing for high quality, more restful sleep.

    The app begins with low-intensity vibration. But if it detects the nightmare event has not been halted, the app increases the intervention intensity. The watch app also sends the collected data to a secure cloud service to facilitate review by a healthcare professional. NightWare also comes equipped with a desktop app to display stress, intervention, and other collected data. Tech-savvy individuals can use the desktop app to review their data, or a healthcare professional could use it to review data for multiple users.

    “We’ve seen a markedly large effect size for improved sleep quality in NightWare open label trials,” NightWare Chief Medical Officer Daniel Karlin, M.D. commented to the press. “We are excited to get folks enrolled in these randomized trials to further verify the observed efficacy.”

    NightWare is early in development and currently not available for sale. The company is currently enrolling patients in two randomized clinical trials (RCT), one of which is being conducted at VA hospitals in Minneapolis and St. Cloud, Minn. The company is also enrolling in a virtual RCT trial broader in geographic scope. If interested, prospective participants can get more information about enrollment at http://bit.ly/2W1it51. 
    Related Searches
    • depression
    • heart
    • cardiac
    • ptsd
    Related Knowledge Center
    • Neurological
    • Digital Health
    Suggested For You
    BRAINBox BRAINBox's Traumatic Brain Injury Test Wins Breakthrough Status
    6 Trends Reshaping Medical Equipment Manufacturing 6 Trends Reshaping Medical Equipment Manufacturing
    FDA Authorizes First Test to Detect Zika Antibodies FDA Authorizes First Test to Detect Zika Antibodies
    FDA Offers Update on Efforts to Ensure Breast Implant Safety FDA Offers Update on Efforts to Ensure Breast Implant Safety
    FDA Approves Device to Help Increase Access to More Lungs for Transplant FDA Approves Device to Help Increase Access to More Lungs for Transplant
    Apple Heart Study Demonstrates Ability of Wearable Technology to Detect Atrial Fibrillation Apple Heart Study Demonstrates Ability of Wearable Technology to Detect Atrial Fibrillation
    Orchestra BioMed Orchestra BioMed's Virtue Sirolimus-Eluting Balloon Wins Breakthrough Status
    FDA Takes Steps to Reduce Surgical Stapler Risks FDA Takes Steps to Reduce Surgical Stapler Risks
    FDA Halts Sale of Pelvic Mesh in U.S. FDA Halts Sale of Pelvic Mesh in U.S.
    FDA Warns Genomics Lab About Illegally Marketing Genetic Test FDA Warns Genomics Lab About Illegally Marketing Genetic Test
    A New, Tailored Review Framework for Artificial Intelligence-Based Devices A New, Tailored Review Framework for Artificial Intelligence-Based Devices
    Cardiac Care on the Can Cardiac Care on the Can
    Study: Apple Watch May Help Flag Heart Rhythm Problems Study: Apple Watch May Help Flag Heart Rhythm Problems
    It’s Time to Embrace Customer Centricity It’s Time to Embrace Customer Centricity
    Sum and Substance: Material Considerations for Changing Design Needs Sum and Substance: Material Considerations for Changing Design Needs

    Related Breaking News

    • Diagnostics | Neurological
      BRAINBox

      BRAINBox's Traumatic Brain Injury Test Wins Breakthrough Status

      BRAINBox TBI is a first-of-its-kind device to aid in concussion diagnosis and prognosis.
      PR Newswire 06.06.19

    • Contract Manufacturing | Digital Health | Software & IT | Surgical
      6 Trends Reshaping Medical Equipment Manufacturing

      6 Trends Reshaping Medical Equipment Manufacturing

      Medical device manufacturers and end users alike must keep an eye on current industry trends in order to prepare and adapt.
      Megan Ray Nichols, Science Writer; Editor, Schooled By Science 05.30.19

    • Diagnostics
      FDA Authorizes First Test to Detect Zika Antibodies

      FDA Authorizes First Test to Detect Zika Antibodies

      The ZIKV Detect 2.0 IgM Capture ELISA is the first Zika diagnostic test the FDA has allowed to be marketed in the U.S.
      U.S. Food and Drug Administration 05.24.19


    • Surgical
      FDA Offers Update on Efforts to Ensure Breast Implant Safety

      FDA Offers Update on Efforts to Ensure Breast Implant Safety

      FDA hopes to ensure that women have the most complete information available to make important breast implant decisions.
      Amy Abernethy, M.D., Ph.D., FDA Principal Deputy Commissioner; Jeff Shuren, M.D., J.D., CDRH Director 05.06.19

    • Surgical
      FDA Approves Device to Help Increase Access to More Lungs for Transplant

      FDA Approves Device to Help Increase Access to More Lungs for Transplant

      The Xvivo Perfusion System allows the transplant team to perform a more careful assessment of lung function.
      PR Newswire 04.30.19

    Loading, Please Wait..

    Trending
    • RJG Names Winners Of 2023 RJG Mold Smart Award
    • Diabetes Innovation: MIT Engineers Unveil Implantable Device With Oxygen Factory
    • A New Approach To Post-Market Surveillance
    • Danaher Names New Environmental And Applied Solutions Company Veralto
    • FDA Clears LiveMetric's Wearable Blood Pressure Monitoring Tech
    Breaking News
    • Heather Danks Named Chief Technology Officer at LEX Diagnostics
    • Vitalchat Awarded Patent for Patient Monitoring, Bandwidth Conservation Tech
    • South Korean Regulators Authorize Expanded NeuroStar TMS Indications
    • Ian T. Meredith Joins Avertix Medical’s Board
    • Hologic, Bayer Team Up for Contrast-Enhanced Mammography
    View Breaking News >
    CURRENT ISSUE

    September 2023

    • Superior Subtractive Solutions for Machining Medtech
    • Medical Device Industry Experts' Thought on Assembly & Automation
    • Power Trip: A Discussion of Custom Medical Electronics
    • The MDR Transition: An Opportunity for Design Change?
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Curcumin May Be As Effective as PPI for Indigestion
    Adding Human Milk Component to Formula Linked to Long-term Cognitive Benefits for Babies
    Women in Nutraceuticals Launches Pilot Mentorship Program
    Coatings World

    Latest Breaking News From Coatings World

    EMPA Develops Flame Resistant Epoxy Resin
    Becker’s Global Mental Health Program Shows Positive Impact
    Pacific Coatings Show Invites Industry to Top-Class Programs
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Vitalchat Awarded Patent for Patient Monitoring, Bandwidth Conservation Tech
    South Korean Regulators Authorize Expanded NeuroStar TMS Indications
    Ian T. Meredith Joins Avertix Medical’s Board
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Nexcella Completes 2nd NXC-201 Engineering Batch
    Almirall Upgrades Werum PAS-X MES
    Rentschler Names Industry Veterans to Leadership Posts
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    GK Hair Expands Color Range to 125 Hues
    WPO and AIPIA Sign MoU to Collaborate on Smart Packaging
    SuperstarBots & Skin Match Redefine Personalized Beauty Recommendations with Social Media Chatbot
    Happi

    Latest Breaking News From Happi

    Daniel C. Liebler Wins 2023 RIFM Board of Directors Excellence in Science Award
    NAD Refers SBLA Beauty To Federal Trade Commission
    Altuzza Fashion Show Features Hairstyles by Jawara Using Fekkai Haircare Products
    Ink World

    Latest Breaking News From Ink World

    HYBRID Software’s PrintFusion for Koenig & Bauer
    Fujifilm Announced European Release of the Acuity Prime Hybrid
    Pacific Coatings Show Invites Industry to Top-Class Programs
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Vibrant Labelexpo Europe 2023 concludes in Brussels
    Kenco Label & Tag adds sheeting system from Daco Solutions
    Bastille Parfums strengthens traceability with Avery Dennison RFID technology
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Lenzing Earns EU Ecolabel at Indonesian Plant
    Albis Starts Up Extra Wide Carding, Blending LIne
    Ahlstrom Launches Nonwoven Laundry Care Product
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    AOFAS, Arthritis Foundation Award Grants to Fuel Ankle Arthritis Research
    Lincotek Marks its 50th Anniversary
    FDA OKs Standalone Indication for ChoiceSpine's Blackhawk Ti Cervical Spacer
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Le Biscuit Boosts Omnichannel Operations with Zebra Technologies
    German Government, Bavaria Commit Support to ams OSRAM
    ASSA ABLOY Acquires Evolis

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login